PRIMARY STUDY

Cannabis sativa as a Treatment for Obesity: From Anti-Inflammatory Indirect Support to a Promising Metabolic Re-Establishment Target

Key Findings:  Phytocannabinoids from Cannabis sativa may be a useful option to reduce and reverse inflammation and comorbidities associated with obesity due to its anti-inflammatory, antioxidant, and neuroprotective properties.

Type of Study:  Meta-analysis

Study Result:  Positive

Study Location(s):  Brazil

Year of Pub:  2021


Cannabinoids Studied:  Cannabidiol (CBD), Tetrahydrocannabinol (THC), Tetrahydrocannabivarin (THCV)

Phytocannabinoid Source:  Unspecified